Gould Capital’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Gould Capital's DGX Position: Q3 2026 in Review
Gould Capital held its Quest Diagnostics (DGX) position steady in Q3 2026 at 189 shares worth $44K. The position accounts for 0.02% of the portfolio, ranked #99.
Gould Capital first reported a position in DGX in Q4 2021 and has held it in 20 quarters since. 1,142 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Gould Capital held 189 shares of Quest Diagnostics worth $44K as of Q3 2026.
- Gould Capital left its Quest Diagnostics share count unchanged in Q3 2026.
- Quest Diagnostics made up 0.02% of Gould Capital's portfolio in Q3 2026, its #99 holding.
- Gould Capital first reported a position in Quest Diagnostics in Q4 2021 and has held it in 20 quarters since.
- 1,142 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Gould Capital's 13F filing for Q3 2026, filed 13 Nov 2026.